State of Wisconsin Investment Board’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10,000
Closed -$377K 2214
2021
Q1
$377K Sell
10,000
-7,500
-43% -$187K ﹤0.01% 1677
2020
Q4
$298K Buy
+17,500
New +$219K ﹤0.01% 1863
2020
Q3
Sell
-17,900
Closed -$109K 2014
2020
Q2
$109K Buy
+17,900
New +$73.7K ﹤0.01% 1628
2019
Q3
Sell
-45,800
Closed -$276K 1601
2019
Q2
$276K Buy
45,800
+1,000
+2% +$9.56K ﹤0.01% 1454
2019
Q1
$600K Buy
44,800
+10,200
+29% +$116K ﹤0.01% 1300
2018
Q4
$322K Sell
34,600
-13,700
-28% -$163K ﹤0.01% 1408
2018
Q3
$672K Sell
48,300
-35,107
-42% -$522K ﹤0.01% 1330
2018
Q2
$1.32M Sell
83,407
-11,100
-12% -$194K ﹤0.01% 1078
2018
Q1
$1.62M Buy
94,507
+74,507
+373% +$1.45M ﹤0.01% 1003
2017
Q4
$438K Hold
20,000
﹤0.01% 1315
2017
Q3
$818K Hold
20,000
﹤0.01% 1157
2017
Q2
$602K Buy
+20,000
New +$624K ﹤0.01% 1227

State of Wisconsin Investment Board's FPRX Position: Q2 2021 in Review

State of Wisconsin Investment Board sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 10,000 shares — an estimated $377K sold.

State of Wisconsin Investment Board first reported a position in FPRX in Q2 2017 and held it in 12 quarters. The position peaked at $1.62M in Q1 2018. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • State of Wisconsin Investment Board reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 10,000 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $377K.
  • State of Wisconsin Investment Board first reported a position in Five Prime Therapeutics, Inc. in Q2 2017 and held it in 12 quarters.
  • State of Wisconsin Investment Board's Five Prime Therapeutics, Inc. position peaked at $1.62M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2021, filed 12 Aug 2021.